SY

SynAct Pharma ABSTO SynAct Pharma Stock Report

Last reporting period 30 Sep, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

0.251

Micro

Exchange

XSTO - Nasdaq STOCKHOLM AB

View Full Company Analysis

Cash flow from operating activities CFO

-0.015 B

Last period CFO ,SEK

20%

CFO has increased in 2 years


What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO of SynAct Pharma ?

SynAct Pharma`s CFO for the period ended 2023-09-30 is -0.015 B SEK

View Full Company Analysis